학술논문

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
Document Type
Article
Source
In The Lancet 2010 376(9737):235-244
Subject
Primary Research
Articles
Language
ISSN
0140-6736